Open-label, Single Center, Non-randomized, Fixed Sequence Phase 1 Drug-drug Interaction Study With LEO 32731 and Midazolam
Clinical trial NCT03126578 · COMPLETED
Trial details
- NCT number
- NCT03126578
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-31
- Primary completion
- 2017-10-20
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.